Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 968 products on this category.

Product data	Purity	Price range	Estimated delivery
N2-Nitroso Palbociclib REF: 4Z-P-196080	- - -	To inquire	Wed 11 Dec 24
Gimeracil Impurity 3 REF: 4Z-G-047003	- - -	To inquire	Wed 11 Dec 24
Carfilzomib Impurity 34 REF: 4Z-C-121037CAS: 2381627-87-6	- - -	To inquire	Wed 11 Dec 24
Abiraterone Mesylate REF: 4Z-A-8242	- - -	To inquire	Wed 11 Dec 24
Carfilzomib Impurity 86 REF: 4Z-C-121091CAS: 3235-82-3	- - -	To inquire	Wed 11 Dec 24
Palbociclib Impurity 88 REF: 4Z-P-196102	- - -	To inquire	Wed 11 Dec 24
N-Nitroso Abiraterone Impurity 33 REF: 4Z-A-8286	- - -	To inquire	Wed 11 Dec 24
Folinic Acid Impurity 12 REF: 4Z-F-068027	- - -	To inquire	Wed 11 Dec 24
Fulvestrant Impurity 24 REF: 4Z-F-3142	- - -	To inquire	Wed 11 Dec 24
Fulvestrant Impurity 25 REF: 4Z-F-3143	- - -	To inquire	Wed 11 Dec 24
Fulvestrant Impurity 23 REF: 4Z-F-3141	- - -	To inquire	Wed 11 Dec 24
Enzalutamide REF: TM-T6002CAS: 915087-33-1	100% - 99.67%	48.00 €~640.00 €	Wed 11 Dec 24
Olaparib Impurity 73 REF: 4Z-O-032079CAS: 2248670-14-4	- - -	To inquire	Wed 11 Dec 24
Palbociclib Impurity 82 REF: 4Z-P-196092CAS: 2172256-78-7	- - -	To inquire	Wed 11 Dec 24
Enzalutamide Impurity 57 REF: 4Z-E-068071	- - -	To inquire	Wed 11 Dec 24
Fulvestrant Impurity 22 REF: 4Z-F-3140	- - -	To inquire	Wed 11 Dec 24
Nintedanib REF: TM-T1777CAS: 656247-17-5	98% - 99.92%	45.00 €~139.00 €	Wed 11 Dec 24
Nintedanib Impurity 77 REF: 4Z-N-066088CAS: 2117628-65-4	- - -	To inquire	Wed 11 Dec 24
Nintedanib Impurity 36 REF: 4Z-N-066053CAS: 1824020-12-3 2055-23-4	- - -	To inquire	Wed 11 Dec 24
Enzalutamide Impurity 16 REF: 4Z-E-068029CAS: 915087-32-0	- - -	To inquire	Wed 11 Dec 24

5mg		48.00 €
10mg		56.00 €
25mg		73.00 €
50mg		94.00 €
100mg		150.00 €
200mg		183.00 €
500mg		268.00 €
1mL*10mM (DMSO)		52.00 €

5mg		45.00 €
10mg		58.00 €
50mg		69.00 €
100mg		90.00 €
200mg		139.00 €
1mL*10mM (DMSO)		55.00 €

Cancer treatment

N2-Nitroso Palbociclib

Ref: 4Z-P-196080

Gimeracil Impurity 3

Ref: 4Z-G-047003

Carfilzomib Impurity 34

Ref: 4Z-C-121037

Abiraterone Mesylate

Ref: 4Z-A-8242

Carfilzomib Impurity 86

Ref: 4Z-C-121091

Palbociclib Impurity 88

Ref: 4Z-P-196102

N-Nitroso Abiraterone Impurity 33

Ref: 4Z-A-8286

Folinic Acid Impurity 12

Ref: 4Z-F-068027

Fulvestrant Impurity 24

Ref: 4Z-F-3142

Fulvestrant Impurity 25

Ref: 4Z-F-3143

Fulvestrant Impurity 23

Ref: 4Z-F-3141

Enzalutamide

Ref: TM-T6002

Olaparib Impurity 73

Ref: 4Z-O-032079

Palbociclib Impurity 82

Ref: 4Z-P-196092

Enzalutamide Impurity 57

Ref: 4Z-E-068071

Fulvestrant Impurity 22

Ref: 4Z-F-3140

Nintedanib

Ref: TM-T1777

Nintedanib Impurity 77

Ref: 4Z-N-066088

Nintedanib Impurity 36

Ref: 4Z-N-066053

Enzalutamide Impurity 16

Ref: 4Z-E-068029